Search bioRxiv⌕ Search

Biology subjects

Dehne, E.-M.

Publications and source records attributed to Dehne, E.-M..

2 recordsLinked to original sources

A Sacrificial 3D Printed Vessel-on-Chip Demonstrates a Versatile Approach to Model Connective Tissue Pathology

For in vitro organ models, perfused vasculature is crucial to overcome nutrient diffusion limits and to generate immunocompetent models by allowing trans-endothelial migration of immune cells in and out of the tissue. However, vasculature is often disregarded due to its complexity to generate and the necessity to integrate flow. The aim here was to overcome these limitations by combining 3D printing and multi-organ-chip technology to generate a vascularized, fibroblast-populated connective tissue matrix on-chip. A 3D printed, sacrificial, water-dissolvable structure was incorporated into a multi-organ-chip to generate hollow channels within a collagen/fibrin hydrogel. Subsequently, the channels were populated with endothelial cells. Different hydrogel concentrations of fibrin were used to mimic healthy and early granulation tissue. The vessels were perfused, and stable metabolic/viability conditions (lactate dehydrogenase, glucose, lactate) acquired after 3 days for 7 days total. In high fibrin gels, angiogenic sprouting and increased secretion of angiogenic cytokines was observed. Perfusion with monocytes revealed differentiation into macrophages and migration across the endothelium into the tissue. In conclusion, the versatile, easy method to pattern hydrogels in multi-organ-chips can serve as the basis to build the next generation of vascularized, immunocompetent human organ models, and opens new possibilities to study health and disease.

bioengineering↗

Towards an autologous iPSC-derived patient-on-a-chip

Microphysiological systems are fundamental for progressing towards a global paradigm shift in drug development through the generation of patient-on-a-chip models. An increasing number of single- and multi-organ systems have been adopted by the pharmaceutical and cosmetic industries for predictive substance testing. These models run on heterogeneous tissues and cell types from different donors. However, a patient is an individual. Therefore, patient-on-a-chip systems need to be built from tissues from one autologous source. Individual on-chip organ differentiation from a single induced pluripotent stem cell source could provide a solution to this challenge.\n\nWe designed a four-organ chip based on human physiology. It enables the interconnection of miniaturized human intestine, liver, brain and kidney equivalents. All four organ models were predifferentiated from induced pluripotent stem cells from the same healthy donor and integrated into the microphysiological system. The cross talk led to further differentiation over a 14-day cultivation period under pulsatile blood flow conditions in one common medium deprived of growth factors. This model platform will pave the way for disease induction and subsequent drug testing.

bioengineering↗